Browsed by
Tag: medical imaging

Setting a Global Priority: Test Once, Sell Everywhere

Setting a Global Priority: Test Once, Sell Everywhere

This piece was originally published in the November 2016 issue of electroindustry. Hans Beinke, Chair, MITA Global Affairs Committee Just as MITA works with Congress and the U.S. Food and Drug Administration to improve regulatory and business conditions, its Global Affairs Committee (GAC) works with partners in an increasingly interconnected world to streamline regulatory procedures and strengthen members’ businesses. When threats to global business emerge or countries enact barriers Read more [...]
Elevating MITA Brand through Standards Development

Elevating MITA Brand through Standards Development

This piece was originally published in the November 2016 issue of electroindustry. Megan A. Hayes, Director, Regulatory and Standards Strategy, MITA Standards facilitate efficient and timely market access for medical imaging products. That’s why MITA develops standards—to improve products for patients. In 2013, MITA successfully lobbied Congress to enact payment differential that provides higher payment for procedures performed with devices that comply with XR 29-2013 Standard Attributes Read more [...]
 X-ray Section Spotlights Recent Successes

 X-ray Section Spotlights Recent Successes

This piece was originally published in the November 2016 issue of electroindustry. Tony Roder, Global Regulatory Affairs Executive, GE Healthcare Recapping 2016 Accomplishments The Computed Radiography and Digital Radiography Group of the MITA X-ray Section published NEMA/MITA XR 30-2016 Quality Control Tools for Digital Projection Radiography in response to a request from the American Association of Physicists in Medicine (AAPM) Task Group (TG) 150 on Acceptance Testing and Quality Read more [...]
DICOM Delivers Interoperability to Cancer Informatics

DICOM Delivers Interoperability to Cancer Informatics

This piece was originally published in the November 2016 issue of electroindustry. David A. Clunie, MD, PixelMed Publishing Cancer is the leading cause of death in many states. Its screening, diagnosis, treatment, and research relies on the interoperability of digital medical imaging systems. That fact is not lost on the National Cancer Institute (NCI), the federal government's principal agency for cancer research and training, located within the National Institutes of Health (NIH). One Read more [...]
Bundled Payments, Bungled Care?

Bundled Payments, Bungled Care?

This piece was originally published in the November 2016 issue of electroindustry. Madeleine Smith, PhD, Director, Government Affairs & Policy, General Electric As financial pressures on the healthcare system rise, the Center for Medicare and Medicaid Services (CMS) and private payers are experimenting with new ways to incentivize the efficient production of healthcare to reduce costs. One popular payment model is the “episode bundle,”[1] where a group of providers receives Read more [...]
Curing Cancer Possible with Medical Imaging

Curing Cancer Possible with Medical Imaging

This piece was originally published in the November 2016 issue of electroindustry. Richard Frank, MD, PhD, FFPM (RCP), Chief Medical Officer, Clinical Strategy and Policy, Siemens Healthineers The Cancer Cure Moonshot Initiative is an ambitious and exciting endeavor that MITA fully supports. Curing cancer is impossible without medical imaging. Screening, surveillance, diagnosis, staging, prognostics, choice of therapy, targeting radiation therapy, monitoring therapeutic benefits, and detecting Read more [...]
Focusing on Regulatory Environment

Focusing on Regulatory Environment

This piece was originally published in the November 2016 issue of electroindustry. Diane Wurzburger, Executive, Regulatory Affairs, GE Healthcare MITA’s Technical and Regulatory Committee (TRC) promotes a regulatory environment that supports growth and innovation in medical imaging. In 2016, the TRC set three priorities: successful Medical Device User Fee Amendments (MDUFA) negotiations; critical to quality (CtQ) engagement, which is part of a of the U.S. Food and Drug Administration Read more [...]
Medical Device Tax Repeal: Good for Patients and Good for the Economy

Medical Device Tax Repeal: Good for Patients and Good for the Economy

This piece was originally published in the November 2016 issue of electroindustry. Andy Dhokai, MPPA, Director, Federal Relations, MITA As congressional action ceased as a prelude to national and local elections, MITA continued to make the case for full repeal of the 2.3 percent excise tax on the sale of medical devices enacted as part of the Affordable Care Act. We are using the first year of a two-year suspension of the tax, passed in December 2015, to show members of Congress and Read more [...]
Standardizing the Value of Quality

Standardizing the Value of Quality

This piece was originally published in the November 2016 issue of electroindustry. Jim Nestel, Manager Service Projects and Installations, Hitachi Medical Systems Only original equipment manufacturer (OEM) service providers are required by the Food and Drug Administration (FDA) to have a quality management system (QMS) to assess medical imaging equipment. Although many non-OEM medical imaging device service providers perform excellent work, the lack of such a requirement leaves the Read more [...]
Working Together in Medical Imaging

Working Together in Medical Imaging

This piece was originally published in the November 2016 issue of electroindustry. Nelson Mendes, CEO, Ziehm Imaging and Chair, MITA Board of Directors As chair of the MITA Board of Directors, I am pleased to reflect on the ways MITA benefits the medical imaging industry, to highlight the work we’ve done in 2016, and to bring attention to the important role membership plays in our interactions with patients, providers, payers, and regulators. MITA’s member companies and staff set Read more [...]